by Richard Daverman, PhD
November 1, 2013 -- Sichuan Kelun Pharmaceutical will not acquire a 20% stake in Lijun International Pharma (HK: 2005), a transaction that was previously announced in December of last year. No reason for the reversal was given. At the time of the original announcement, Kelun said it would pay $135 million to buy the stake from two major Lijun shareholders. More details....
Stock Symbol: (SHE: 002422)
Help employers find you! Check out all the jobs and post your resume.
